Key result
Mitral valve repair in a low-volume center achieved a 30-day mortality of 2.1% overall (3% for functional and 0% for degenerative regurgitation), with long-term survival of 75.6% and 90.9%.
Why the study?
This study evaluated early- and long-term outcomes of mitral valve repairs performed in a low-volume cardiac surgery centre in the Caribbean.
Cohort (n=96)
No
Absolute Event Rate: 3% vs 0%
Mitral valve repair can be performed safely with good early and long-term results even in a low-volume center.
Mitral valve repair may be feasible in low-volume centers; leaves open whether volume thresholds warrant referral to high-volume sites.
INTRODUCTION: This study examines early- and long-term outcomes of mitral valve repairs in a low-volume cardiac surgery centre in the Caribbean. METHODS: Ninety-six consecutive patients underwent mitral valve repair from April 2009 to December 2018. Patients were divided into two groups: functional mitral regurgitation requiring simple mitral annuloplasty (FMR, n=63) or structural degenerative mitral regurgitation requiring more complex repair (DMR, n=33). Data collected prospectively were retrospectively analysed from the unit-maintained cardiac surgery database. RESULTS: Thirty-day mortality in the whole series was 2.1%, with 3% in the FMR group and 0% in the DMR group. Early post-operative echocardiography in the FMR group demonstrated 51 patients (83.6%) without mitral regurgitation, 8 patients (13.1%) with trivial to mild regurgitation, and 2 patients (3.3%) with moderate regurgitation. However, at a mean follow-up of 98.2±50.8, only 21 patients (42.8%) were in NYHA class I, with 7 (14.2%) in class II, 16 (32.6%) in class III, and 5 (10.2%) in class IV. There were 9 cardiac-related deaths at final follow-up, with freedom from re-operation and survival of 98% and 75.6%, respectively. In the DMR group, early post-operative echocardiography demonstrated 29 patients (87.9%) without mitral regurgitation, 3 patients (9.1%) with trivial regurgitation and 1 patient (3.0%) with mild regurgitation. At a mean follow-up of 114.1±25.4 months, there was a good functional post-operative status in this group with 93.3% in NYHA class I, and 6.7% in class II. No patient required reintervention, 96.3% of patients had mild or no mitral regurgitation and survival was 90.9%. CONCLUSION: Despite challenges of maintaining skills in a low-volume centre, mitral valve repair can be performed safely with good early- and long-term results.
No takes yet. Share an insight, caveat, or question.
Ramsingh et al. (2022) conducted a cohort in Mitral regurgitation (n=96). Mitral valve repair vs. Functional vs structural degenerative mitral regurgitation was evaluated on 30-day mortality. Mitral valve repair in a low-volume center achieved a 30-day mortality of 2.1% overall (3% for functional and 0% for degenerative regurgitation), with long-term survival of 75.6% and 90.9%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: